8-K: Cycurion Faces Nasdaq Delisting, Appeals Decision

Cycurion, Inc. has received a determination letter from Nasdaq to delist its common stock due to a sustained low bid price, prompting an appeal process that will allow trading to continue.

Summary

• Cycurion, Inc. received a determination letter from Nasdaq on July 10, 2026, indicating the company's common stock is subject to delisting.
• The reason for the delisting determination is that the closing bid price of the company's common stock remained below the $1.00 minimum requirement for 31 consecutive business days, from May 26, 2026, to July 9, 2026.
• This non-compliance is with Nasdaq Listing Rule 5550(a)(1).
• Due to a 1-for-30 reverse stock split executed on October 27, 2025, Cycurion is not eligible for the standard 180-day compliance period.
• Trading suspension was expected to commence on July 21, 2026, if no hearing was requested.
• Cycurion plans to request a hearing before the Nasdaq Hearings Panel by the July 17, 2026 deadline.
• A timely hearing request will halt the suspension of trading and the filing of a Form 25-NSE, allowing the stock to continue trading on Nasdaq during the appeal.
• There is no guarantee the appeal will be successful or that the company will regain compliance.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the delisting notice, despite the company's efforts to appeal and maintain operations.

Positives

• Cycurion's common stock will continue to trade on Nasdaq during the appeal process.
• The company plans to request a hearing before the Nasdaq Hearings Panel, providing an opportunity to contest the delisting.
• The company states that this matter does not impact its operations or strategic execution.
• Cycurion reports an annual revenue run rate exceeding $28 million, supported by contracted backlog and a growing pipeline.
• The company has secured multi-year agreements, indicating ongoing business momentum.

Negatives

• The company's common stock is subject to delisting from Nasdaq due to failing to meet the minimum bid price requirement.
• The closing bid price has been below $1.00 for 31 consecutive business days.
• The company is not eligible for the standard 180-day compliance period due to a recent reverse stock split.
• Trading suspension was scheduled to begin on July 21, 2026, if no appeal was filed.
• There is no assurance that the Nasdaq Hearings Panel will grant continued listing or that the company will regain compliance.

Risks

• The primary risk is the potential delisting of Cycurion's common stock from Nasdaq, which could significantly impact liquidity and investor confidence.
• Failure to regain compliance with Nasdaq listing requirements following the hearing could lead to permanent delisting.
• The company's ability to raise capital may be hindered if its securities are delisted.
• The ongoing appeal process and potential for delisting could distract management and impact business operations.
• The market valuation may not appropriately reflect the company's underlying fundamentals, as stated by management.

Future Outlook

Cycurion plans to request a hearing before the Nasdaq Hearings Panel to appeal the delisting determination. The company states its business momentum remains strong and it continues to generate revenue growth. There can be no assurance of a successful appeal or regaining compliance with Nasdaq listing requirements.

Management Comments

• "We are fully prepared to proceed with the Nasdaq Hearings Panel process. During this period, we are continuing to develop a comprehensive, data-driven record of trading activity, supported by internal analysis and external market data. Our focus remains on ensuring that the Company's market valuation appropriately reflects its underlying fundamentals and that our shareholders benefit from a transparent and orderly trading environment."
• "This matter does not impact Cycurion's operations or strategic execution."
• "The Company continues to generate revenue growth through organic expansion, strategic acquisitions, and long-term customer contracts."
• "The Company remains committed to disciplined execution, transparency with shareholders, and pursuing all appropriate avenues to support fair market conditions and long-term value creation."

Industry Context

StockSavvy.ai notes that Nasdaq delisting notices due to low stock price are a recurring challenge for smaller public companies, often triggered by market sentiment, financial performance, or strategic missteps. Companies typically have a period to regain compliance or appeal, but the process can be arduous and uncertain.

Stakeholder Impact

• Shareholders: Potential for increased volatility, reduced liquidity, and uncertainty regarding the future listing of their shares. A delisting could negatively impact share value.
• Creditors: While not directly addressed, a delisting could signal financial distress, potentially impacting the company's ability to service debt.
• Employees: Uncertainty about the company's future could affect morale and job security.
• Customers: Continued operations are stated, but a delisting could raise concerns about the long-term viability of the company as a supplier.

Next Steps

• Cycurion will timely request a hearing before the Nasdaq Hearings Panel.
• The company will prepare materials to support its case for continued listing.
• The Nasdaq Hearings Panel will review the case and make a determination.
• Cycurion will continue to advance its review of trading activity through forensic analysis and engagement with advisors.

Key Dates

Recommendation

The company is facing a significant challenge with Nasdaq delisting, which introduces substantial risk. However, the appeal process is underway, and the company claims business momentum remains strong with a substantial revenue run rate. Given the uncertainty of the appeal outcome and the potential for continued trading, a 'hold' recommendation is appropriate for seasoned investors who can tolerate higher risk, while awaiting further clarity from the Nasdaq Hearings Panel decision.

Keywords

Nasdaq delisting, minimum bid price, Cycurion, CYCU, reverse stock split, hearing request, listing compliance, Form 8-K